Scandinavian ChemoTech starts a feasibility study in the USA
Today Scandinavian ChemoTech has signed an agreement with the US based company Diversified Consultant Group LLC that will be responsible for performing a feasibility study. This study is aiming to identify how Scandinavian ChemoTech should design a “Go-to-Market” strategy when launching its animal care product vetIQure in the USA.The US market for vetIQure is of great significance as the Cancer therapy market for pets is estimated to over MUSD 800/y and growing with a double-digit rate.
Diversified Consultant Group LLC was founded by the CEO Danny Nesrallah, who has extensive experience